Kadir Ahmad Ridwan

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Tianjin University of Science and Technology(Current)

China International Science and Technology Cooperation

Kadir Ahmad Ridwan is an author at Tianjin University of Science and Technology specializing in oncology, nanoparticle-delivered prodrugs, and drug delivery.

ORCID

Publications per year

2021–2022

Publications

Tumor vasculature-targeting PEGylated peptide-drug conjugate prodrug nanoparticles improve chemotherapy and prevent tumor metastasis

Tiantian Hao, Ying Fu, Yang Yao et al. · European Journal of Medicinal Chemistry · 2021 · 32 citations

Pharmacy, Oncology, Pharmaceutics +16

Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib

Ying Fu, Rengui Saxu, Kadir Ahmad Ridwan et al. · Molecules · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2